With most businesses of conglomerates not doing well, the stocks are being shunned by the market. A look at what went wrong and whether these scrips will make a comeback.
It is happening, but nobody seems to be talking about it. Over the last one year, and particularly in the last six months, conglomerate stocks are being given the short shrift by the market.
A year or two ago, well-diversified was a term used to shower praises on these very companies. Economies of scale, exposure to several key sectors in one stock, strong project ma-nagement skills were some of the adjectives used to recommend them as good bets.
Today, buying interest in these scrips has ebbed considerably. Though hard data is not available, market sources confirm that delivery buying in these scrips has thinned significantly. Says Alok Vajpeyi, head of equities, BZW, Over the past six months, all the key conglomerates
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
